Staar Surgical CEO Stephen Farrell and Board of Directors Chair Elizabeth Yeu have stepped down from the company’s board, ...
The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion offer.
GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), ...
After the termination of the proposed acquisition by Alcon, STAAR has announced changes to its board of directors in a cooperation agreement with Broadwood Partners. 1 ...
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of ...
Preliminary net sales of $94.7 million, up 6.9% compared to $88.6 million in the prior year period. Preliminary net sales included $25.9 million related to the previously disclosed December 2024 ICL ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...
GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback